SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-039294
Filing Date
2022-06-24
Accepted
2022-06-24 17:19:48
Documents
1
Period of Report
2022-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4526
  Complete submission text file 0001209191-22-039294.txt   5862
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET NEW YORK NY 10022
Business Address
Urist Marshall (Reporting) CIK: 0001838139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 221040945